Open AccessComparative Efficacy of Sunitinib versus Sorafenib as First-Line Treatment for Patients with Metastatic Renal Cell Carcinoma
Author(s) -
Seongjoon Park,
JaeLyun Lee,
Inkeun Park,
Kwonoh Park,
Yongcheol Ahn,
JinHee Ahn,
Dae-Ho Lee,
Shin Ahn,
Cheryn Song,
Jun Hyuk Hong,
ChoungSoo Kim,
Hanjong Ahn
Publication year - 2012
Publication title -
chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.539
H-Index - 54
eISSN - 1421-9794
pISSN - 0009-3157
DOI - 10.1159/000346484
Subject(s) - sunitinib , sorafenib , renal cell carcinoma , medicine , oncology , carcinoma , cancer research , hepatocellular carcinoma
This study investigated the efficacy and toxicity of sorafenib and sunitinib as primary treatment for patients with metastatic renal cell carcinoma (mRCC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom